Diagnosis of hidden peritoneal metastases in gastric cancers

Phase 2

Recruiting

• Conditions: Gastric cancer.; Malignant neoplasm of stomach, unspecified; C16.9

• Registration Number: IRCT20180720040533N2
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Existence of confirmed gastric cancer in tissue biopsy
The tumor is T3 or higher on histological examination
The exact stage of the disease is diagnosed by CT scan with or without endosonography
Patients aged 20-75 years

Exclusion Criteria

Existence of metastases proven in histological or radiological examinations
Presence of tissue metastasis during surgery
Clear seeding to the peritoneum during surgery
Intolerance to general anesthesia
Existence of any contraindications for diagnostic laparoscopy
History of receiving any radiotherapy or adjuvant chemotherapy before diagnostic laparoscopy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The result of sampling from omentum. Timepoint: one time and 10 days after biopsy. Method of measurement: Based on biopsy results.;The result of cytology of free fluid or abdominal lavage fluid. Timepoint: one time, 10 days after drawing the liquid. Method of measurement: Based on the pathology result.;Presence of ascites during surgery. Timepoint: Once and at the beginning of surgery. Method of measurement: Direct observation during surgery.;Depth of penetration of tumor tissue in adjacent tissue layers. Timepoint: Once during surgery. Method of measurement: Direct observation during surgery.;Extent of adjacent or distant lymph nodes involved by tumor tissue. Timepoint: Once during surgery. Method of measurement: Direct observation during surgery.